NCT03621124

Brief Summary

The purpose of this pilot research is to study brown adipose tissue, a type of fat that increases metabolism (burns energy) during exposure to cold, and how it may contribute to the weight loss observed in cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 8, 2018

Completed
8 days until next milestone

Study Start

First participant enrolled

August 16, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2020

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

1.8 years

First QC Date

August 1, 2018

Last Update Submit

April 8, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in resting energy expenditure between brown adipose tissue (BAT)-positive and BAT-negative patients with cancer.

    Characterization of the energy metabolism profiles of cancer patients with and without evidence of BAT activation will be assessed utilizing one sided t-test.

    27 Months

Secondary Outcomes (1)

  • Difference in energy expenditure between room temperature and response to warm exposure (energy expenditure) in BAT-positive and BAT-negative cancer patients.

    27 Months

Study Arms (2)

Brown Adipose Tissue Positive patients

Patients with known malignancy and incidental finding of positron emission tomography/ computerized tomography (PET/CT) scans positive for brown adipose tissue (BAT). After obtaining informed consent and all initial screening visit procedures, patients will participate in two four-hour recording sessions in the whole room indirect calorimeter to assess resting energy expenditure, and patient's thermal (comfort) response to the temperature of the room.

Procedure: Resting Energy ExpenditureOther: Thermal Comfort Questionnaire

Brown Adipose Tissue Negative Patients

Patients with known malignancy and no evidence of brown adipose tissue BAT activity positron emission tomography/ computerized tomography (PET/CT) scans to be matched to group 1 for primary tumor and stage, sex, age (±5 years), BMI (±3 Kg/m2). After obtaining informed consent and all initial screening visit procedures, patients will participate in two four-hour recording sessions in the whole room indirect calorimeter to assess resting energy expenditure, and patient's thermal (comfort) response to the temperature of the room.

Procedure: Resting Energy ExpenditureOther: Thermal Comfort Questionnaire

Interventions

During each visit, the participant will be assessed in a resting state in a stable temperature controlled environment, and will undergo tests to find out how the body adjusts its metabolism to different temperatures.

Also known as: ENRGEXP
Brown Adipose Tissue Negative PatientsBrown Adipose Tissue Positive patients

Patients will be given a questionnaire to assess their thermal response (whether they felt warmer or colder) during each study visit.

Brown Adipose Tissue Negative PatientsBrown Adipose Tissue Positive patients

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients equal to or greater than forty years of age with an active cancer diagnosis.

You may qualify if:

  • ≥ 40 years of age
  • Have active cancer diagnosis.
  • Have had a PET/CT scan within the past 12 months at time of enrollment.
  • Ability to understand and the willingness to sign a written informed consent document

You may not qualify if:

  • Current use of beta-blockers
  • Women who are pregnant or unsure of their pregnancy status
  • Women who are breastfeeding
  • Suffers from severe claustrophobia
  • Diagnosed with a serious psychiatric condition which could impede the judgement of the investigators, and/or the successful conduct of the recording.
  • In remission stage for cancer diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University/ Massey Cancer Center

Richmond, Virginia, 23298-0070, United States

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Energy Metabolism

Intervention Hierarchy (Ancestors)

Metabolism

Study Officials

  • Francesco S Celi, MD, MHSc

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2018

First Posted

August 8, 2018

Study Start

August 16, 2018

Primary Completion

May 20, 2020

Study Completion

May 20, 2020

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations